Despite increasing interest in the use of human enhancement drugs (HEDs), our understanding of this phenomenon and the regulatory framework used to address it has lagged behind. Encompassing public health, epidemiology, neuroethics, sport science, criminology, and sociology, this book brings together a broad spectrum of scholarly insights and research expertise from leading authorities to examine key international issues in the field of HEDs. As "traditional" and other "new" drug markets have occupied much of the academic attention, there has been a lack of scholarly focus on human enhancement drugs. This book provides readers with a much-needed understanding of the illicit drug market of HEDs. The authors, from a variety of cultural contexts, disciplines and perspectives, include both academics and practitioners. Topics explored in this collection amongst others include:

• The anti-doping industry and performance and image enhancing drugs

• Steroids and gender

• The use of cognitive enhancing drugs in academia

• The use of sunless synthetic tanning products

• The (online) trade of HEDs

• Regulations of the enhancement drugs market

This collection will serve as a reference for students, academics, practitioners, law enforcement and others working in this area to reflect on the current state of research and consider future priorities. This detailed exploration will provide a valuable knowledge base for those interested in human enhancement drugs, while also promoting critical discussion.

chapter 1|10 pages

An introduction to human enhancement drugs

ByKatinka van de Ven, Kyle J. D. Mulrooney, Jim McVeigh

part I|1 pages

Understanding the use of human enhancement drugs in society

chapter 2|14 pages

More than unnatural masculinity

13Gendered and queer perspectives on human enhancement drugs
ByKathryn (Kate) Henne, Bridget Livingstone

chapter 3|13 pages

The anti-doping industry coming of age

In search of new markets
ByBengt Kayser, Verner Møller

chapter 4|14 pages

The social construction of human enhancement

Implications for sports
ByJay Coakley

chapter 5|14 pages

Steroid madness

Has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
ByKyle J. D. Mulrooney, Katinka van de Ven, Jim McVeigh, Rick Collins

chapter 6|15 pages

Licit forms of performance enhancement and possible links with IPED use

Current knowledge and future directions
ByIan Boardley

part II|1 pages

Human enhancement drugs, harms and public health

chapter 7|16 pages

Infections and risk among people who use image and performance enhancing drugs

ByVivian Hope, Jenny Iversen

chapter 8|11 pages

“Objects in the mirror are larger than they appear”

Steroids and body image disorders
ByScott Griffiths

chapter 9|16 pages

Estimated prevalence, effects and potential risks of substances used for cognitive enhancement

ByJamie Tully, Catharine Montgomery, Larissa J. Maier, Harry R. Sumnall

chapter 10|15 pages

“Beauty through the eye of a needle”

An online study of the practices and beliefs of people who inject performance and image enhancing drugs (PIEDs)
ByRebekah Brennan, John S. G. Wells, Marie Claire Van Hout

chapter 11|13 pages

The use of sunless synthetic tanning products

ByMarie Claire Van Hout, Jim McVeigh

chapter 12|14 pages

The non-medical uses of prescription stimulants in the Australian context

ByMatthew Dunn, Cynthia Forlini

part III|1 pages

Illicit human enhancement drug markets and their suppliers

chapter 13|15 pages

The (online) supply of illicit lifestyle medicines

172A criminological study
ByAlexandra Hall, Georgios A. Antonopoulos

chapter 14|16 pages

A preliminary attempt to scope the market for doping products in Italy

ByLetizia Paoli, Alessandro Donati

chapter 15|14 pages

Trust, risk and deceit in the illicit medicines market

An analysis of the on- and offline trust relations between sellers and buyers of illicit medicines
ByRosa Koenraadt

chapter 16|12 pages

The open bar has closed

Changes in the patterns of doping supply in elite cycling
ByBertrand Fincoeur

chapter 17|17 pages

The supply of Image and Performance Enhancing Drugs (IPED) to local non-elite users in England

Resilient traditional and newly emergent methods
ByRoss Coomber, Mike Salinas

part IV|1 pages

Responding to human enhancement drugs

chapter 18|15 pages

Different users, different interventions

249On the ideal typology of anabolic-androgenic steroid use and its implications for prevention, harm reduction and treatment
ByAnders Schmidt Vinther, Ask Vest Christiansen

chapter 19|16 pages

The war on anabolic-androgenic steroids

An examination of U.S. legislative and enforcement efforts
ByRick Collins

chapter 20|17 pages

Preventing image and performance enhancing drug use

It’s not all chalk and talk
ByGeoff Bates, Susan Backhouse

chapter 22|11 pages

One size does not fit all

Tackling the issue of weight-loss drug use
ByJennifer Germain, Charlotte McLean, Conan Leavey